Prevalence and Characteristics of Chemotherapy-related Cognitive Impairment in Patients with Breast Cancer |
Park, Jin-Hee
(College of Nursing, Ajou University)
Bae, Sun Hyoung (Department of Nursing, College of Medicine, Dong-A University) Jung, Yong-Sik (Department of Surgery, School of Medicine, Ajou University) Jung, Young-Mi (College of Nursing, Ajou University) |
1 | Matsuda T, Takayama T, Tashiro M, Nakamura Y, Ohashi Y, Shimozuma K. Mild cognitive impairment after adjuvant chemotherapy in breast cancer patients-evaluation of appropriate research design and methodology to measure symptoms. Breast Cancer. 2005;12(4):279-287. DOI |
2 | Myers JS, Teel C. Oncology nurses' awareness of cognitive impairment secondary to chemotherapy. Clinical Journal of Oncology Nursing. 2008;12(5):725-729. http://dx.doi.org/10.1188/08.cjon.725-729 DOI ScienceOn |
3 | Hutchinson AD, Hosking JR, Kichenadasse G, Mattiske JK, Wilson C. Objective and subjective cognitive impairment following chemotherapy for cancer: A systematic review. Cancer Treatment Reviews. 2012;38(7):926-934. http://dx.doi.org/10.1016/j.ctrv.2012.05.002 DOI ScienceOn |
4 | Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: Results of a prospective, randomized, longitudinal trial. Cancer. 2004;100(11):2292-2299. http://dx.doi.org/10.1002/cncr.20272 DOI ScienceOn |
5 | Collins B, Mackenzie J, Kyeremanteng C. Study of the cognitive effects of chemotherapy: Considerations in selection of a control group. Journal of Clinical and Experimental Neuropsychology. 2013;35(4):435-444. http://dx.doi.org/10.1080/13803395.2013.781995 DOI ScienceOn |
6 | Jung KW, Won YJ, Kong HJ, Oh CM, Lee DH, Lee JS. Cancer statistics in Korea: Incidence, mortality, survival, and prevalence in 2011. Cancer Research and Treatment. 2014;46(2):109-123. http://dx.doi.org/10.4143/crt.2014.46.2.109 DOI ScienceOn |
7 | Munir F, Burrows J, Yarker J, Kalawsky K, Bains M. Women's perceptions of chemotherapy-induced cognitive side affects on work ability: A focus group study. Journal of Clinical Nursing. 2010;19(9-10):1362-1370. http://dx.doi.org/10.1111/j.1365-2702.2009.03006.x DOI ScienceOn |
8 | Park JH, Bae SH. A meta-analysis of chemotherapy related cognitive impairment in patients with breast cancer. Journal of Korean Academy of Nursing. 2012;42(5):644-658. http://dx.doi.org/10.4040/jkan.2012.42.5.644 DOI ScienceOn |
9 | Ahles TA, Saykin AJ. Breast cancer chemotherapy-related cognitive dysfunction. Clinical Breast Cancer. 2002;3(Suppl 3):S84-S90. DOI ScienceOn |
10 | Myers JS. Chemotherapy-related cognitive impairment: The breast cancer experience. Oncology Nursing Forum. 2012;39(1):E31-E40. http://dx.doi.org/10.1188/12.onf.e31-e40 DOI |
11 | Jansen CE, Cooper BA, Dodd MJ, Miaskowski CA. A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients. Supportive Care in Cancer. 2011;19(10):1647-1656. http://dx.doi.org/10.1007/s00520-010-0997-4 DOI |
12 | Jim HS, Donovan KA, Small BJ, Andrykowski MA, Munster PN, Jacobsen PB. Cognitive functioning in breast cancer survivors: A controlled comparison. Cancer. 2009;115(8):1776-1783. http://dx.doi.org/10.1002/cncr.24192 DOI ScienceOn |
13 | Hermelink K, Untch M, Lux MP, Kreienberg R, Beck T, Bauerfeind I, et al. Cognitive function during neoadjuvant chemotherapy for breast cancer: Results of a prospective, multicenter, longitudinal study. Cancer. 2007;109(9):1905-1913. http://dx.doi.org/10.1002/cncr.22610 DOI ScienceOn |
14 | Avisar A, River Y, Schiff E, Bar-Sela G, Steiner M, Ben-Arye E. Chemotherapy-related cognitive impairment: Does integrating complementary medicine have something to add? Review of the literature. Breast Cancer Research and Treatment. 2012;136(1):1-7. http://dx.doi.org/10.1007/s10549-012-2211-5 DOI ScienceOn |
15 | Ouimet LA, Stewart A, Collins B, Schindler D, Bielajew C. Measuring neuropsychological change following breast cancer treatment: An analysis of statistical models. Journal of Clinical and Experimental Neuropsychology. 2009;31(1):73-89. http://dx.doi.org/10.1080/13803390801992725 DOI ScienceOn |
16 | Vearncombe KJ, Rolfe M, Wright M, Pachana NA, Andrew B, Beadle G. Predictors of cognitive decline after chemotherapy in breast cancer patients. Journal of the International Neuropsychological Society. 2009;15(6):951-962. http://dx.doi.org/10.1017/s1355617709990567 DOI ScienceOn |
17 | Janelsins MC, Kesler SR, Ahles TA, Morrow GR. Prevalence, mechanisms, and management of cancer-related cognitive impairment. International Review of Psychiatry. 2014;26(1):102-113. http://dx.doi.org/10.3109/09540261.2013.864260 DOI ScienceOn |
18 | Ferguson RJ, McDonald BC, Saykin AJ, Ahles TA. Brain structure and function differences in monozygotic twins: Possible effects of breast cancer chemotherapy. Journal of Clinical Oncology. 2007;25(25):3866-3870. http://dx.doi.org/10.1200/jco.2007.10.8639 DOI ScienceOn |
19 | Stewart A, Bielajew C, Collins B, Parkinson M, Tomiak E. A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. The Clinical Neuropsychologist. 2006;20(1):76-89. http://dx.doi.org/10.1080/138540491005875 DOI ScienceOn |
20 | Jansen CE, Miaskowski CA, Dodd MJ, Dowling GA. A meta-analysis of the sensitivity of various neuropsychological tests used to detect chemotherapy-induced cognitive impairment in patients with breast cancer. Oncology Nursing Forum. 2007;34(5):997-1005. http://dx.doi.org/10.1188/07.onf.997-1005 DOI |
21 | Tager FA, McKinley PS, Schnabel FR, El-Tamer M, Cheung YK, Fang Y, et al. The cognitive effects of chemotherapy in post-menopausal breast cancer patients: A controlled longitudinal study. Breast Cancer Research and Treatment. 2010;123(1):25-34. http://dx.doi.org/10.1007/s10549-009-0606-8 DOI |
22 | Wagner LI, Sweet J, Butt Z, Lai JS, Cella D. Measuring patient self-reported cognitive function: Development of the functional assessment of cancer therapy-cognitive function instrument. The Journal of Supportive Oncology. 2009;7(6):W32-W39. |
23 | Chelune GJ, Naugle RI, Luders H, Sedlak J, Awad IA. Individual change after epilepsy surgery: Practice effects and base-rate information. Neuropsychology. 1993;7(1):41-52. http://dx.doi.org/10.1037/0894-4105.7.1.41 DOI |
24 | Lezak MD, Howieson DB, Loring DW, Hannay J, Fischer JS. Neuropsychological assessment. 4th ed. New York, NY: Oxford University Press;2004. |
25 | Von Ah D, Habermann B, Carpenter JS, Schneider BL. Impact of perceived cognitive impairment in breast cancer survivors. European Journal of Oncology Nursing. 2013;17(2):236-241. http://dx.doi.org/10.1016/j.ejon.2012.06.002 DOI ScienceOn |
26 | Cheung YT, Tan EH, Chan A. An evaluation on the neuropsychological tests used in the assessment of postchemotherapy cognitive changes in breast cancer survivors. Supportive Care in Cancer. 2012;20(7):1361-1375. http://dx.doi.org/10.1007/s00520-012-1445-4 DOI ScienceOn |
27 | Chung BY, Cho EJ. Correlates influencing cognitive impairment in breast cancer patients receiving chemotherapy. Asian Oncology Nursing. 2012;12(3):221-229. http://dx.doi.org/10.5388/aon.2012.12.3.221 DOI ScienceOn |
28 | Moon S, Kim SH, Kim MJ. Perceived cognitive function and related factors in Korean women with breast cancer. Asian Nursing Research. 2011;5(2):141-150. http://dx.doi.org/10.1016/s1976-1317(11)60022-4 DOI ScienceOn |
29 | Kaiser J, Bledowski C, Dietrich J. Neural correlates of chemotherapy-related cognitive impairment. Cortex. 2014;54:33-50. http://dx.doi.org/10.1016/j.cortex.2014.01.010 DOI ScienceOn |
30 | Collins B, Mackenzie J, Stewart A, Bielajew C, Verma S. Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment. Psycho-Oncology. 2009;18(2):134-143. http://dx.doi.org/10.1002/pon.1379 DOI ScienceOn |